Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan in PACAP38-induced migraine
NCT03881644Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sumatriptan in migraine without aura (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoints: Incidence of migraine and Effect of Sumatriptan. Started Jul 2018; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine without aura
Beyond the preview
Go deeper on NCT03881644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03881644.